Stocks News

LAST PRICE
15.8300
TODAY'S CHANGE (%)
Trending Up0.0400 (0.2533%)

Bid / Lots
15.5000/ 1
Ask / Lots
16.1600/ 1
Open / Previous Close
15.7300 / 15.7900
Day Range
Low 15.5700
High 16.3300
52 Week Range
Low 11.3900
High 29.7000
Volume
358,738
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Mar 21, 2024
- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure, from 5:30PM ET on Thursday Mar 21, 2024 by Business Wire
  5:30PM ET on Thursday Mar 21, 2024 by Business Wire
  Companies Mentioned: QTRX
  Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories interested in offering Tau based research and diagnostic testing services. Quanterix has secured over thirty U.S. patents protecting our innovative ultra-sensitive research products and high-definition diagnostics, and we continue to secure additional patent protection, both in the United States and abroad. Multiple patents--including U.S. Patent No. 11,275,092--are directed specifically to our novel approach to measuring Tau protein levels in biologic samples.
- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure, from 5:30PM ET on Thursday Mar 21, 2024 by Dow Jones
  5:30PM ET on Thursday Mar 21, 2024 by Dow Jones
  Companies Mentioned: QTRX
  BILLERICA, Mass.--(BUSINESS WIRE)--March 21, 2024--
  Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories interested in offering Tau based research and diagnostic testing services. Quanterix has secured over thirty U.S. patents protecting our innovative ultra-sensitive research products and high-definition diagnostics, and we continue to secure additional patent protection, both in the United States and abroad. Multiple patents--including U.S. Patent No. 11,275,092--are directed specifically to our novel approach to measuring Tau protein levels in biologic samples.

Apr 17, 2024
- NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024, from 4:05PM ET on Wednesday Apr 17, 2024 by GlobeNewswire
  4:05PM ET on Wednesday Apr 17, 2024 by GlobeNewswire
  Companies Mentioned: NPCE
Apr 16, 2024
- --TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target, from 8:08AM ET on Tuesday Apr 16, 2024 by MT Newswires
  8:08AM ET on Tuesday Apr 16, 2024 by MT Newswires
  Companies Mentioned: LAB
Apr 9, 2024
- Harvard Bioscience Reducing Headcount, from 1:38PM ET on Tuesday Apr 09, 2024 by MT Newswires
  1:38PM ET on Tuesday Apr 09, 2024 by MT Newswires
  Companies Mentioned: HBIO
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth, from 9:00AM ET on Tuesday Apr 09, 2024 by GlobeNewswire
  9:00AM ET on Tuesday Apr 09, 2024 by GlobeNewswire
  Companies Mentioned: HBIO
Apr 8, 2024
- Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging, from 8:00AM ET on Monday Apr 08, 2024 by GlobeNewswire
  8:00AM ET on Monday Apr 08, 2024 by GlobeNewswire
  Companies Mentioned: LAB
Apr 4, 2024
- --Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target, from 10:33AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:33AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: LAB
- Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday, from 8:55AM ET on Thursday Apr 04, 2024 by MT Newswires
  8:55AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: IBB, STAA, XLV, LAB, BMY, MGNX
- Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb, from 3:35AM ET on Thursday Apr 04, 2024 by MT Newswires
  3:35AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: LAB, BMY
Apr 3, 2024
- Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan(R) Platform for Translational Medicine Research, from 4:01PM ET on Wednesday Apr 03, 2024 by GlobeNewswire
  4:01PM ET on Wednesday Apr 03, 2024 by GlobeNewswire
  Companies Mentioned: LAB
Mar 27, 2024
- NeuroPace to Present at the Needham 23rd Annual Healthcare Conference, from 4:05PM ET on Wednesday Mar 27, 2024 by GlobeNewswire
  4:05PM ET on Wednesday Mar 27, 2024 by GlobeNewswire
  Companies Mentioned: NPCE

Quanterix Corp
NASDAQ:QTRXUnited States

Search Criteria

Mar 21, 2024

Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure, from 5:30PM ET on Thursday Mar 21, 2024 by Business Wire

Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure, from 5:30PM ET on Thursday Mar 21, 2024 by Dow Jones

Peers Headlines

Apr 17, 2024

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024, from 4:05PM ET on Wednesday Apr 17, 2024 by GlobeNewswire

Apr 16, 2024

--TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target, from 8:08AM ET on Tuesday Apr 16, 2024 by MT Newswires

Apr 9, 2024

Harvard Bioscience Reducing Headcount, from 1:38PM ET on Tuesday Apr 09, 2024 by MT Newswires

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth, from 9:00AM ET on Tuesday Apr 09, 2024 by GlobeNewswire

Apr 8, 2024

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging, from 8:00AM ET on Monday Apr 08, 2024 by GlobeNewswire

Apr 4, 2024

--Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target, from 10:33AM ET on Thursday Apr 04, 2024 by MT Newswires

Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday, from 8:55AM ET on Thursday Apr 04, 2024 by MT Newswires

Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb, from 3:35AM ET on Thursday Apr 04, 2024 by MT Newswires

Apr 3, 2024

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan(R) Platform for Translational Medicine Research, from 4:01PM ET on Wednesday Apr 03, 2024 by GlobeNewswire

Mar 27, 2024

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference, from 4:05PM ET on Wednesday Mar 27, 2024 by GlobeNewswire